blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3593810

EP3593810 - METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.04.2022
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  21.05.2021
FormerGrant of patent is intended
Status updated on  06.04.2021
FormerRequest for examination was made
Status updated on  17.07.2020
FormerThe application has been published
Status updated on  13.12.2019
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Biocardia, Inc.
125 Shoreway Road Suite B
San Carlos, CA 94070 / US
[2020/03]
Inventor(s)01 / WONG PO FOO, Cheryl
3 Mahogany Drive
San Rafael, CA 94903 / US
02 / ALTMAN, Peter
2056 Menalto Avenue
Menlo Park, CA 94025 / US
 [2021/25]
Former [2020/03]01 / WONG PO FOO, Cheryl
3471 Victoria Avenue
Santa Clara, CA 95051 / US
02 / ALTMAN, Peter
2056 Menalto Avenue
Menlo Park, CA 94025 / US
Representative(s)Gregson, Anna Louise, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[2021/25]
Former [2020/03]Gregson, Anna Louise, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London
SE1 9SG / GB
Application number, filing date19182443.228.10.2014
[2020/03]
Priority number, dateUS201361896450P28.10.2013         Original published format: US 201361896450 P
[2020/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3593810
Date:15.01.2020
Language:EN
[2020/03]
Type: B1 Patent specification 
No.:EP3593810
Date:23.06.2021
Language:EN
[2021/25]
Search report(s)(Supplementary) European search report - dispatched on:EP16.12.2019
ClassificationIPC:A61K35/28, G01N33/569
[2020/03]
CPC:
G01N33/56966 (EP,US); A61K35/28 (EP,US); G01N2333/70596 (EP,US);
G01N2800/52 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/34]
Former [2020/03]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR MESSUNG DES POTENZIALS EINER THERAPEUTISCHEN WIRKSAMKEIT UND ZUR FESTLEGUNG VON DOSIERUNGEN FÜR AUTOLOGE ZELLTHERAPIEN[2020/03]
English:METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES[2020/03]
French:PROCÉDÉS DE MESURE DE RISQUE D'EFFICACITÉ THÉRAPEUTIQUE ET DE DÉFINITION DE DOSAGES POUR THÉRAPIES CELLULAIRES AUTOLOGUES[2020/03]
Examination procedure13.07.2020Amendment by applicant (claims and/or description)
13.07.2020Examination requested  [2020/34]
13.07.2020Date on which the examining division has become responsible
07.04.2021Communication of intention to grant the patent
13.05.2021Fee for grant paid
13.05.2021Fee for publishing/printing paid
13.05.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14857113.6  / EP3063172
Opposition(s)24.03.2022No opposition filed within time limit [2022/22]
Fees paidRenewal fee
25.06.2019Renewal fee patent year 03
25.06.2019Renewal fee patent year 04
25.06.2019Renewal fee patent year 05
28.10.2019Renewal fee patent year 06
27.10.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.10.2014
AL23.06.2021
AT23.06.2021
CY23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
MK23.06.2021
MT23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
TR23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
[2024/42]
Former [2024/29]HU28.10.2014
AL23.06.2021
AT23.06.2021
CY23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
MK23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
TR23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2024/23]HU28.10.2014
AL23.06.2021
AT23.06.2021
CY23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
MK23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2023/33]HU28.10.2014
AL23.06.2021
AT23.06.2021
CY23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2023/30]AL23.06.2021
AT23.06.2021
CY23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2022/48]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
IE28.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2022/37]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
LU28.10.2021
BE31.10.2021
CH31.10.2021
LI31.10.2021
Former [2022/36]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
IT23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
LU28.10.2021
BE31.10.2021
Former [2022/35]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
LU28.10.2021
BE31.10.2021
Former [2022/33]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
BE31.10.2021
Former [2022/29]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SI23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
Former [2022/26]AL23.06.2021
AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
Former [2022/21]AT23.06.2021
CZ23.06.2021
DK23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
Former [2022/11]AT23.06.2021
CZ23.06.2021
EE23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
PL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
IS23.10.2021
PT25.10.2021
Former [2022/09]AT23.06.2021
CZ23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
RO23.06.2021
RS23.06.2021
SE23.06.2021
SK23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
PT25.10.2021
Former [2022/08]AT23.06.2021
CZ23.06.2021
ES23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
RS23.06.2021
SE23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
Former [2022/07]AT23.06.2021
FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
NL23.06.2021
RS23.06.2021
SE23.06.2021
SM23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
Former [2021/51]FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
RS23.06.2021
SE23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
Former [2021/49]FI23.06.2021
HR23.06.2021
LT23.06.2021
LV23.06.2021
SE23.06.2021
BG23.09.2021
NO23.09.2021
GR24.09.2021
Former [2021/46]FI23.06.2021
LT23.06.2021
BG23.09.2021
Documents cited:Search[A]US2007148668  (RICH IVAN N [US]) [A] 1-10* the whole document *;
 [A]WO2009146495  (SYDNEY WEST AREA HEALTH SERVICE [AU], et al) [A] 1-10 * the whole document *;
 [AD]WO2010127342  (BIOCARDIA INC [US], et al) [AD] 1-10 * the whole document *;
 [IDY]US8496926  (DE LA FUENTE LUIS M [AR], et al) [ID] 1,2,4-7 * column 1, lines 29-31; column 2, lines 10-26; claim 1 * [Y] 3,8-10;
 [YD]  - EMERSON C PERIN ET AL, "A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)", AMERICAN HEART JOURNAL, ELSEVIER, AMSTERDAM, NL, vol. 161, no. 6, doi:10.1016/J.AHJ.2011.01.028, ISSN 0002-8703, (20110113), pages 1078 - 1087.e3, (20110325), XP028374595 [YD] 3,8-10 * page 1080, paragraphs "Bone marrow mononuclear cell studies", "Flow cytometry" *

DOI:   http://dx.doi.org/10.1016/j.ahj.2011.01.028
 [Y]  - EMERSON C. PERIN ET AL, "Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure : The FOCUS-CCTRN Trial", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, US, (20120425), vol. 307, no. 16, doi:10.1001/jama.2012.418, ISSN 0098-7484, XP055494135 [Y] 8-10 * page 4, first paragraph *

DOI:   http://dx.doi.org/10.1001/jama.2012.418
 [A]  - DORIS TAYLOR ET AL, "Improved Myocardial Function in Patients with Chronic Ischemic Heart Disease Treated with Transendocardial Delivery of Bone Marrow Mononuclear Cells Depends Upon Input Cell Phenotype and Function", CIRCULATION, (20121101), vol. 21, page 16354, XP055363957 [A] 1-10 * the whole document *
 [A]  - M BEKSAC ET AL, "Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic?", BONE MARROW TRANSPLANTATION, GB, (20121105), vol. 47, no. 11, doi:10.1038/bmt.2011.240, ISSN 0268-3369, pages 1391 - 1396, XP055364342 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1038/bmt.2011.240
 [A]  - Michael Keeney ET AL, "Hematopoietic Stem Cells: Issues in Enumeration", Applications of Flow Cytometry in Stem Cell Research and Tissue Regeneration, Hoboken, NJ, USA, John Wiley & Sons, Inc., (20100728), pages 115 - 134, doi:10.1002/9780470631119.ch9, ISBN 978-0-470-54398-6, XP055420438 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1002/9780470631119.ch9
Examination   - JOHNSTON PETER V. ET AL, "Not All Stem Cells Are Created Equal : The Case for Prospective Assessment of Stem Cell Potency in the CardiAMP Heart Failure Trial", CIRCULATION RESEARCH, US, (20180928), vol. 123, no. 8, doi:10.1161/CIRCRESAHA.118.313425, ISSN 0009-7330, pages 944 - 946, XP055783274

DOI:   http://dx.doi.org/10.1161/CIRCRESAHA.118.313425
by applicantUS7097832
 US7695712
 US2010127342
 US8496926
    - LOSORDO DW et al., "Intramyocardial, Autologous CD34+Cell Therapy for Refractory Angina", Circ Res., (20110000), vol. 109
    - GOODCHILD T et al., J Am Coll Cardiol Intv., (20090000), vol. 2, pages 1005 - 16
    - Am Heart J, (20110000), vol. 161, pages 1078 - 1087
    - JAMA, (20120000), vol. 307, no. 16
    - DE LA FUENTE et al., "Transendocardial Autologous Bone Marrow in Myocardial Infarction Induced Heart Failure, Two Year Follow up in an Open Label Phase I Study", Eurointervention, (20110000), vol. 7, doi:doi:10.4244/EIJV7I7A127, pages 805 - 812, XP008184243

DOI:   http://dx.doi.org/10.4244/EIJV7I7A127
    - LOKEN MR et al., "Flow Cytomeric Analysis of Human Bone Marrow II. Normal B Lymphocyte Development", Blood, (19870000), vol. 70, no. 5, pages l316 - 1324, XP002364963
    - DENG et al., American Journal of Transplantation, (20060000), vol. 6, pages 150 - 160
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.